KUNOVSKÝ, Lumír, Zdeněk KALA, Filip MAREK, Jiří DOLINA, Karolina POREDSKÁ, Lenka KUČEROVÁ, Klára BENEŠOVÁ and Ladislav MITÁŠ. The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn’s disease. International Journal of Colorectal Disease. New York: Springer, 2019, vol. 34, No 2, p. 347-351. ISSN 0179-1958. Available from: https://dx.doi.org/10.1007/s00384-018-3122-7.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn’s disease
Authors KUNOVSKÝ, Lumír (203 Czech Republic, belonging to the institution), Zdeněk KALA (203 Czech Republic, belonging to the institution), Filip MAREK (203 Czech Republic, guarantor, belonging to the institution), Jiří DOLINA (203 Czech Republic, belonging to the institution), Karolina POREDSKÁ (203 Czech Republic, belonging to the institution), Lenka KUČEROVÁ (203 Czech Republic, belonging to the institution), Klára BENEŠOVÁ (203 Czech Republic, belonging to the institution) and Ladislav MITÁŠ (203 Czech Republic, belonging to the institution).
Edition International Journal of Colorectal Disease, New York, Springer, 2019, 0179-1958.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30212 Surgery
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.108
RIV identification code RIV/00216224:14110/19:00108963
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s00384-018-3122-7
UT WoS 000455824400018
Keywords in English Crohn’s disease; Czech cohort; Disease course; Genetics; Inflammatory bowel disease; Intestinal resection; NOD2/CARD15; Surgery
Tags 14110213, 14110223, 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 11/5/2020 08:16.
Abstract
Purpose: Crohn’s disease (CD) belongs to chronic disorders with unpredictable disease course. The aim of this study was to identify how genetic testing (NOD2/CARD15) can be used in patients with CD to predict the need for surgical treatment (to define an aggressive type of disease where the patient can profit from early surgery). Methods: The patients who were tested genetically had undergone a surgery due to CD at the Department of Surgery University Hospital Brno Bohunice between 2010 and 2016. The control group consisted of patients with CD who had been diagnosed with CD at least 5 years prior to the testing and had not required any surgical intervention. The second control group was healthy subjects. Results: In total, there were 117 operated patients for CD, 77 patients with CD that had not undergone surgery for CD and 30 healthy subjects. For patients with at least one genetic mutation, the risk of the necessity of surgical treatment of CD is 1.96 times higher than for patients with no mutation. Patients with two or more mutations were generally operated on at a younger age, in a shorter time after being diagnosed and each patient had a partial resection of the ileum. Conclusion: The group of operated patients with CD had a significantly higher distribution of at least one genetic mutation as opposed to the non-operated group. In patients with two or more mutations, the disease course was more aggressive. This group of patients might profit from the conservative top-down or early surgical therapy.
PrintDisplayed: 27/4/2024 04:49